BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Epigenica Expands Into Japan Through PrimeTech Partnership To Advance Epigenetic Research

Epigenica AB, a company commercializing advanced tools for epigenetic analysis, announced a distribution agreement with PrimeTech Co., Ltd., a leadin...

March 20, 2026 | News

DNA Script Expands Global Reach Of SYNTAX Platform Through Strategic Distribution Partnerships

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, announced it has signed distribution ag...

March 19, 2026 | News

PRISM BioLab And Receptor.AI Partner To Build AI Guided Platform For Challenging Drug Targets

PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. announced that they have entered into a drug discovery collaboration agreement (the "Collaborat...

March 16, 2026 | News

Meiji Seika Pharma Initiates Phase I Trial Of ME3241 PD 1 Agonist Antibody For Autoimmune Diseases

Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced that it has in...

March 12, 2026 | News

Merck And Cyto Facto Partner To Advance Lentiviral Manufacturing For Cell And Gene Therapies In APAC

Collaboration aims to support development of a robust lentiviral production platform for gene therapy applications Merck’s VirusExpress™293T...

March 12, 2026 | News

Curatis Partners With Neupharma To Advance Corticorelin Development For Brain Tumour Related Edema In Japan

Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developi...

March 12, 2026 | News

Fujitsu And DT Axis Partner To Accelerate Software As Medical Device Development In Japan

Fujitsu Limited and DT-Axis Co., Ltd. announced the commencement of a collaboration aimed at advancing digital health. The two companies have signed a memo...

March 10, 2026 | News

ISCT And JSRM Form Five Year Global Partnership To Accelerate Clinical iPSC Therapies

The International Society for Cell & Gene Therapy (ISCT), the translation-focused global community of cell and gene therapy experts and the Japanese So...

March 05, 2026 | News

Ono Pharmaceutical And Congruence Expand Research Alliance Into Neurology And Immunology

Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candi...

March 04, 2026 | News

Lynk Pharmaceuticals Reports Positive Phase III Results For Zemprocitinib In Atopic Dermatitis

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammat...

March 03, 2026 | News

PHCbi Launches LiCellGrow Cell Expansion System To Advance CGT Manufacturing Efficiency

PHC Corporation’s Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter “PHCbi”), a global provid...

March 03, 2026 | News

Takeda And Protagonist Secure FDA Priority Review For Rusfertide In Polycythemia Vera

Rusfertide Demonstrated Significant Improvements in Hematocrit Control, Phlebotomy Reduction and Patient Reported Outcomes for Patients with Polycythem...

March 03, 2026 | News

Pfizer And Astellas Report Strong Phase III EV 304 Results For PADCEV Plus Pembrolizumab In MIBC

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with ove...

March 02, 2026 | News

Japan Launches Elevidys Gene Therapy For Young Children With Duchenne Muscular Dystrophy

- Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years - Company is eligible ...

February 27, 2026 | News

Stay Connected